Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
Abstract Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson’s disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopath...
Guardado en:
Autores principales: | Rubén Fernández-Santiago, Anna Esteve-Codina, Manel Fernández, Francesc Valldeoriola, Almudena Sanchez-Gómez, Esteban Muñoz, Yaroslau Compta, Eduardo Tolosa, Mario Ezquerra, María J. Martí |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7246e0b9640e48e58c03a535ba5224ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017) -
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
por: Paula Ramos-Gonzalez, et al.
Publicado: (2021) -
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Mary K. Herrick, et al.
Publicado: (2021) -
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm F, et al.
Publicado: (2016) -
Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
por: Chandra Lebovitz, et al.
Publicado: (2021)